| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Tuesday, June 24, 2025 07:14 AM
UBS on Tuesday initiated coverage of building materials group Amrize (NYSE:AMRZ) with a Neutral rating and a $53 price target, citing strong medium-term fundamentals and significant cash generation.
|
|
Tuesday, June 24, 2025 04:40 AM
Amarin Corporation (NASDAQ:AMRN) traded ~7% higher in the premarket on Tuesday after the company announced an exclusive license and supply agreement with Italian pharmaceutical firm Recordati S.p.A.
|
|
Thursday, May 15, 2025 05:00 PM
Amarin Co. plc (NASDAQ:AMRN – Get Free Report) passed above its 200-day moving average during trading on Thursday .The stock has a 200-day moving average of $10.28 and traded as high as $10.57 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/06/25 | 49.18 | 50.39 | 49.06 | 49.55 | 3,979,857 |
|
|
||||
|
|
||||
|
|